Search results
etsy.com
- There are several types of art that are recommended for use during this time, including drawing and sketching, painting, collage, sculpture, and photography. These activities can help pregnant women to explore their emotions, connect with their bodies, and create meaningful artwork that captures the beauty of this unique stage in their lives.
shunchild.com › article › what-kind-of-art-art-using-for-pregnancyThe Beauty Of Pregnancy Art: Exploring Different Mediums To ...
Jan 31, 2024 · Recommendations for initial antiretroviral therapy (ART) during pregnancy are intended for people who have never received ART or antiretroviral (ARV) drugs for prophylaxis (i.e., people who are ARV-naive) and show no evidence of significant resistance to regimen components (see Pregnant People With HIV Who Have Never Received Antiretroviral Drugs).
People also ask
When should pregnant women start art?
Can pregnant women do art?
Should art changes be considered during pregnancy?
What types of art should expectant mothers engage in during pregnancy?
Jan 25, 2023 · A: The known benefits of ART in pregnant persons living with HIV for optimizing maternal and infant health and preventing transmission of HIV to the infant clearly outweigh potential adverse...
- People on Fully Suppressive Antiretroviral Therapy
- Bictegravir
- Cobicistat-Boosted Regimens
- Doravirine
- Oral Two-Drug Regimens
- Long-Acting Injectable Cabotegravir and Rilpivirine
- People Not on Fully Suppressive Art When Becoming Pregnant
- References
In general, people who are already on a fully suppressive antiretroviral regimen when pregnancy occurs should continue their antiretroviral therapy (ART) regimens. The Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission (the Panel) recommends that effective ART regimens should not be changed just because the regimen ...
PK data on bictegravir (BIC) in human pregnancy are now available from two clinical studies and a case series.6,7 Drug levels are lower in the second and third trimesters than in nonpregnant or postpartum individuals and are reduced in later pregnancy to a greater degree for BIC than dolutegravir (DTG). However, viral suppression was generally main...
Clinicians and pregnant people should be aware that the use of atazanavir/COBI, darunavir/COBI, or elvitegravir/cobicistat (EVG/c) is associated with lower plasma drug exposures (both of COBI and of the drug being boosted) during the second and third trimesters of pregnancy due to the physiologic changes associated with pregnancy. These low drug ex...
PK data on DOR in human pregnancy are available only from PK modeling data based on ex vivo studies of placental transfer.9,10 Patients who become pregnant with viral suppression while receiving regimens with DOR should be counseled about limited available data, see Doravirine. Clinicians and patients should reach a shared decision about continuing...
Currently, no data exist on the use of oral two-drug regimens in pregnancy (e.g., DTG plus lamivudine [3TC] and DTG plus rilpivirine [RPV]). However, for both DTG/3TC and DTG/RPV, there are data in nonpregnant persons showing noninferiority when compared to a standard three-drug regimen.11,12 The component drugs in each of the oral two-drug regimen...
Data on long-acting injectable cabotegravir (CAB)and RPV are currently limited to a small number of patients without HIV who became pregnant while enrolled in trials of long-acting injectable CAB for pre-exposure prophylaxis and stopped the medication once pregnancy was recognized, usually in the first trimester.14-16 In these patients, the pharmac...
People who are not fully suppressed and who are currently taking ART should be evaluated carefully for adherence barriers, drug–drug interactions, drug–food requirements, and HIV drug resistance, with every effort made to achieve rapid and full viral suppression through adherence interventions or medication changes (see Pregnant People Who Have Not...
Floridia M, Ravizza M, Pinnetti C, et al. Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy. HIV Clin Trials. 2010;11(6):303-311. Ava...Peyronnet V, Warszawski J, Sibiude J, et al. Does changing antiretroviral therapy in the first trimester of pregnancy for safety concerns have an impact on viral suppression? J Acquir Immune Defic...Crauwels HM, Osiyemi O, Zorrilla C, et al. Reduced exposure to darunavir and cobicistat in HIV-1-infected pregnant women receiving a darunavir/cobicistat-based regimen. HIV Med. 2019;20(5):337-343....Momper J, Best BM, Wang J, et al. Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV. AIDS. 2018;32(17):2507-2516. Available at: https://pubmed.ncbi.nlm.nih.gov/3013...Jan 23, 2024 · When engaging in any form of art during pregnancy, it is important to prioritize safety and comfort. Pregnant women should ensure that the art supplies they are using are non-toxic and that they are working in a well-ventilated area. They should also listen to their bodies and take breaks as needed to rest and avoid excessive strain.
Antiretroviral therapy (ART) during pregnancy should focus on the reduction of perinatal transmission and the treatment of maternal human immunodeficiency virus (HIV) disease. ART can reduce...
Jan 13, 2021 · All pregnant people with HIV should initiate ART as early in pregnancy as possible, regardless of their HIV RNA level or CD4 T lymphocyte count, to maximize their health and prevent perinatal HIV...
When to start ART in pregnancy. HIV-infected pregnant women in need of ART for their own health should start ART as soon as feasible regardless of gestational age and continue throughout pregnancy, childbirth, breastfeeding (if breastfeeding), and thereafter. What ART regimen to initiate.
